Novel therapeutic strategies based on toll-like receptor signaling

By Lawton J.A.   Ghosh P.  

Current Opinion in Chemical Biology, Vol. 7, Iss. 4, 2003-08 ,pp. : 446-451

Elsevier

Access to resources Recommend Favorite

Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents

By Baldridge Jory R   McGowan Patrick   Evans Jay T   Cluff Christopher   Mossman Sally   Johnson David   Persing David  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 7, 2004-07 ,pp. : 1129-1138

Informa Healthcare

Access to resources Recommend Favorite

Dependence of pathogen molecule-induced Toll-like receptor activation and cell function on Neu1 sialidase

By Amith Schammim Ray   Jayanth Preethi   Franchuk Susan   Siddiqui Sarah   Seyrantepe Volkan   Gee Katrina   Basta Sameh   Beyaert Rudi   Pshezhetsky Alexey   Szewczuk Myron  

Glycoconjugate Journal, Vol. 26, Iss. 9, 2009-12 ,pp. : 1197-1212

Springer Publishing Company

Access to resources Recommend Favorite

Monophosphoryl lipid A is an lipopolysaccharide-derived Toll-like receptor 4 agonist which may improve Alzheimer's disease pathology

By Wang David B  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 12, 2013-12 ,pp. : 1639-1641

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of PDE modulation in treating heart disease

By Knight Walter   Yan Chen  

Future Medicinal Chemistry, Vol. 5, Iss. 14, 2013-09 ,pp. : 1607-1620

Future Science

Access to resources Recommend Favorite